Skip to main content
Premium Trial:

Request an Annual Quote

BioCommerce Week s Index to the Diversified Molecular Biology Tools Companies: Jan 27, 2005

 

BioCommerce Week’s Index to the
Diversified Molecular Biology Tools Companies
Company
Ticker
Current Price (Jan. 25, 2005)
Last Price (Jan. 18 2005)
% Change
Agilent
A
21.80
22.43
-2.81
Applied Biosystems
ABI
19.88
20.95
-5.11
BD
BDX
54.29
55.01
-1.31
Beckman
BEC
67.88
69.95
-2.96
Bio-Rad
BIO
56.09
57.99
-3.28
Bruker
BRKR
3.50
3.85
-9.09
GE
GE
35.70
35.96
-0.72
Harvard Bio
HBIO
4.23
4.29
-1.40
Invitrogen
IVGN
67.43
69.30
-2.70
Molecular Devices
MDCC
19.35
19.61
-1.33
PerkinElmer
PKI
21.02
21.08
-0.28
Sigma
SIAL
62.31
59.53
4.67
Stratagene
STGN
6.68
6.70
-0.30
Thermo
TMO
29.75
29.37
1.29
Waters
WAT
47.06
48.18
-2.32
Index Average
34.46
34.95
-1.38

 

Bruker Shares Fall as BCW Index Drops 1.4 Percent

As the earnings season began for the molecular biology tools companies last week, the BioCommerce Week Index ended a two-week rally, finishing down 1.4 percent for the five-day period ending Tuesday.

Led by a 9-percent drop in the stock price of Bruker BioScience, the BCW Index closed at $34.46, down from last week’s $34.95.

GE, the first company among the 15 firms whose share prices are tracked on the BCW Index, finished the week down 0.7 percent, despite a sparkling earnings report (see page 8).

Applied BioSystems, which finished a portion of its strategic reorganization by naming an executive for its flagship division (see page 2), trailed Bruker as its shares dropped 5 percent for the period.

Shares of Bio-Rad, Beckman Coulter, Agilent, and Invitrogen all dropped between 2 and 3 percent, as 13 of the 15 companies saw shares fall.

Broadly, the BCW Index outperformed the Dow, which was down 1.5 percent for the period, the S&P 500 fell just over 2 percent and the Nasdaq dropped 4 percent. The Amex pharma index fell 2 percent and the biotech index dropped 4 percent.

Following is a schedule of quarterly financial reporting dates for the BCW Index companies:

  • Agilent: Feb. 14
  • Applied Biosystems: Jan. 27
  • Becton Dickinson: Jan. 26
  • Beckman Coulter: Jan. 28
  • Bio-Rad: Feb. 17
  • Bruker BioScience: No date set
  • General Electric: Jan. 21
  • Harvard Bioscience: March 4
  • Invitrogen: No date set
  • Molecular Devices: Feb. 11
  • PerkinElmer: Jan. 27
  • Sigma-Aldrich: Feb. 8
  • Stratagene: Feb. 7
  • Thermo: Feb. 2
  • Waters: Jan. 27

 

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.